Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-07-09Clinical Trial Update: What is the Predictive Value of the Reflux Impact Scale
AstraZeneca reports a terminated clinical trial evaluating the predictive value of the Reflux Impact Scale for GERD-related symptoms.
-
FDA approval · 2008-06-30FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2008-06-25FDA Approved: FAMOTIDINE — Original Application (Mylan Institutional LLC)
The FDA approved a generic famotidine product from Mylan Institutional LLC under an original ANDA.
-
FDA approval · 2008-06-18FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approved a supplemental application for PRILOSEC OTC (omeprazole magnesium) from The Procter & Gamble Manufacturing Company.
-
FDA approval · 2008-06-12FDA Approved: METOCLOPRAMIDE — Original Application (Ipca Laboratories Limited)
FDA approved the original generic application for metoclopramide by Ipca Laboratories Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-06-11Clinical Trial Update: Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD) [Phase 1]
A Phase 1 pharmacokinetic study of esomeprazole magnesium in children aged 1 to 11 years with endoscopically proven gastroesophageal reflux …
-
CLINICAL_TRIALS trial_result · 2008-06-05Clinical Trial Update: Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy [NA]
This completed clinical trial evaluated the effectiveness of esophageal capsule endoscopy for screening patients with gastroesophageal reflu…
-
FDA approval · 2008-06-03FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved Sagent Pharmaceuticals' supplemental application for famotidine under an existing ANDA, updating the product's approved lab…
-
FDA approval · 2008-06-03FDA Approved: FAMOTIDINE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for famotidine from Sagent Pharmaceuticals, confirming the generic product under ANDA075651.
-
CLINICAL_TRIALS trial_result · 2008-05-30Clinical Trial Update: Registry Study of the NDO Surgical Plicator for the Treatment of GERD [NA]
A registry trial of the NDO Surgical Plicator for gastroesophageal reflux disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-05-30Clinical Trial Update: Multi-Center Study of the NDO Surgical Plicator Utilizing Multiple Implants for the Treatment of GERD [NA]
A multi-center clinical trial evaluating the NDO Surgical Plicator for gastroesophageal reflux disease was terminated; no results or phase i…
-
CLINICAL_TRIALS trial_result · 2008-05-23Clinical Trial Update: Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children [Phase 3]
Phase 3 clinical trial evaluating lidocaine topical spray as an adjuvant to upper gastrointestinal endoscopy in children has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease [NA]
A completed clinical trial evaluated the effectiveness of radiofrequency treatment for Gastroesophageal Reflux Disease.
-
FDA approval · 2008-05-20FDA Approved: FAMOTIDINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for famotidine (Hikma Pharmaceuticals USA Inc.). The approval updates the labeling to reflect additi…
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease
A completed clinical trial evaluated high-dose esomeprazole in combination with baclofen for treating gastroesophageal reflux disease in pat…
-
FDA approval · 2008-04-21FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID (lansoprazole) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-04-21FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for PREVACID SOLUTAB (lansoprazole) filed by Takeda Pharmaceuticals America, expanding the product's…
-
CLINICAL_TRIALS research · 2008-03-31Clinical Trial Update: Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population
This clinical trial update describes the development of a disease-specific quality-of-life questionnaire for gastroesophageal reflux disease…
-
CLINICAL_TRIALS trial_result · 2008-03-26Clinical Trial Update: The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients
The trial update reports termination of a study examining the roles of visceral hyperalgesia, gastroesophageal reflux disease, and esophagea…
-
CLINICAL_TRIALS trial_result · 2008-03-24Clinical Trial Update: Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers [Phase 1]
Phase 1 dose-escalation study of S-Tenatoprazole-Na (30, 60, 90, 120 mg) in healthy volunteers to characterize dose-related pharmacodynamics…
-
FDA approval · 2008-03-20FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC, authorizing the continued marketing of a…
-
FDA approval · 2008-02-29FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) submitted by The Procter & Gamble Manufacturing Company. Thi…
-
FDA approval · 2008-02-27FDA Approved: NEXIUM — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved Nexium (esomeprazole magnesium) through its Original Application, marking its original approval as a proton pump inhibitor for …
-
FDA approval · 2008-02-27FDA Approved: FAMOTIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for famotidine from Teva Pharmaceuticals USA, Inc., updating the approved generic product.
-
CLINICAL_TRIALS trial_result · 2008-02-18Clinical Trial Update: LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)
This is a completed clinical trial update for GERD patients in the LIFE NIS study, evaluating burden of disease using the GERD Impact Scale.…